Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02948855

Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

Study on Regulation of LncRNA to Regulatory B Cells(Bregs) Through Notch Pathway in Patients With Thymoma and Autoimmune Diseases

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Initially investigators will find LncRNA which to be able to affect Notch2 signaling pathway; then confirm the relationship between Notch2 and LncRNA, and analysis the regulation mode of LncRNA to Notch2 signaling pathway, and to observe the correlation between LncRNA and thymoma complicated with autoimmune diseases.

Detailed description

1. This study plans to research the correlation between Bregs and thymoma complicated with autoimmune diseases and the regulation the severity of the disease. 2. Clarify different expression levels of Notch2 signaling pathway in thymoma complicated with autoimmune diseases, and the effect on Regulatory B Cells(Bregs). 3. Find the effective regulation mode of Notch2 signaling pathway and the regulation of Bregs cell development and function in LncRNA.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2016-10-31
Last updated
2018-05-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02948855. Inclusion in this directory is not an endorsement.